HAVN — HAVN Life Sciences Balance Sheet
0.000.00%
Last trade - 00:00HealthcareHighly SpeculativeMicro CapValue Trap
- CA$0.59m
- CA$0.60m
- CA$0.28m
Annual balance sheet for HAVN Life Sciences, fiscal year end - April 30th, CAD millions except per share, conversion factor applied.
2020 April 30th | 2021 April 30th | 2022 April 30th | |
|---|---|---|---|
| Period Length: | — | — | — |
| Source: | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final |
| Cash | |||
| Cash and Short Term Investments | 1.62 | 9.4 | 1.06 |
| Net Total Accounts Receivable | |||
| Net Total Receivables | 0.251 | 0.21 | 0.319 |
| Total Inventory | |||
| Prepaid Expenses | |||
| Total Current Assets | 1.94 | 10.6 | 2.75 |
| Gross Property, Plant And Equipment | |||
| Accumulated Depreciation | |||
| Net Property, Plant And Equipment | — | 0.681 | 0.356 |
| Net Intangible Assets | |||
| Other Long Term Assets | |||
| Total Assets | 1.94 | 14.2 | 4.06 |
| Accounts Payable | |||
| Payable / Accrued | |||
| Accrued Expenses | |||
| Notes Payable / Short Term Debt | |||
| Current Portion of Long Term Debt / Capital Leases | |||
| Total Other Current Liabilities | |||
| Total Current Liabilities | 0.041 | 0.715 | 0.608 |
| Capital Lease Obligations | |||
| Total Long Term Debt | |||
| Total Debt | |||
| Total Liabilities | 0.041 | 1.04 | 0.918 |
| Common Stock | |||
| Additional Paid In Capital | |||
| Retained Earnings (Accumulated Deficit) | |||
| Total Equity | 1.9 | 13.2 | 3.14 |
| Total Liabilities & Shareholders' Equity | 1.94 | 14.2 | 4.06 |
| Total Common Shares Outstanding |